• 2019: German Oncology Center; Limassol, Cyprus
  Consultant Radiation Oncology
• 2012 – 2014: University Clinic for Radiation Oncology; Inselspital Bern, Switzerland
• 2015 – 2016: Consultant Radiation Oncology (Breast & Gynecological Tumors)
• 2017 – 2019: University Clinic for Internal Medicine; Inselspital Bern, Switzerland
• 2014 – 2015: Clinical Oncology Ward
• 2017: Board Certification Exam in Radiation Oncology

2016 – 2017: Department of Genitourinary Oncology
David H. Koch Center for applied research of genitourinary cancers
MD Anderson Cancer Center; Houston, USA

2015: Faculty of Medicine, University of Bern, Switzerland

• 2005 – 2011: Studies of Medicine at the Ruprecht-Karls-University Heidelberg, Germany
• 2011 – 2012: Practical Year (Training Electives)
• 2012: Final State Examination (Staatsexamen)

• 05/2015: Radiation Protection Course, SRO (Kantonsspital Aarau, Switzerland)
• 10/2015: Physics Course, SRO (Paul Scherrer Institute Villigen, Switzerland)
• 10/2015: SAKK Investigators’ Education (Good Clinical Practice) Course (Bern, Switzerland)
• 11/2015: ESTRO Course: IGRT and chemotherapy in gynaecological cancer,
• 03/2016: focus on adaptive brachytherapy (UMC Utrecht, Netherlands)
  ESTRO Course: Modern Brachytherapy Techniques (University of Florence, Italy)
• 08/2016: North and South American Prostate Cancer Symposium (Houston, USA)
• 01/2017: Mechanisms of Castration Resistance & Metastasis in Prostate Cancer
  Prostate Cancer Moon Shot Symposium (Houston, USA)
• Since 2017: GEC-ESTRO yearly Brachytherapy Workshops

• Since 2014: ASCO (American Society of Clinical Oncology)
• Since 2014: SASRO (Scientific Association of Swiss Radiation Oncology)
• Since 2015: ESTRO (European Society for Radiotherapy and Oncology)
• Since 2016: ASTRO (American Society for Radiation Oncology)
• Since 2016: ESMO (European Society for Medical Oncology)

Reviewing Work for Peer – Reviewed Journals

• Since 2015: Radiation Oncology (www.RO-Journal.com)
• Since 2017: OncoTargets and Therapy (www.dovepress.com)
• Since 2018: BMC Cancer (https//bmccancer.biomedcentral.com)

Peer – Reviewed Publications

• In Print: A candidate androgen signaling signature predictive of response to Abiraterone acetate in men with metastatic castration resistant prostate cancer. Tsikkinis A., Efstathiou E., et al
  http://dx.doi.org/xxx (European Journal of Cancer)
• 04/2019: Breast Cancer Care in Northern Ethiopia – Planning for a Better Future
  Deressa B., Tsikkinis A., Rauch D., et al
  http://dx.doi.org/10.1186/s12885-019-5612-6 (BMC Cancer)
• 02/2019: Dosimetric Analysis of the InCise 2 Multi Leaf Collimator and IRIS-Based
  Stereotactic Radiotherapy Plans for Brain and Liver Tumors
  https://doi.org/10.1088/2057-1976/ab0beb (Biomed. Phys. Eng. Express)
• 05/2018: Clinical trials involving positron emission tomography and prostate cancer: An analysis of the ClinicalTrials.gov database
  Cihoric N., Vlaskou BE, Tsikkinis A., Ghadjar P. et al
  http://dx.doi.org/10.1186/s13014-018-1057-3 (Radiation Oncology Journal)
• 08/2017: Highly conformal combined radiotherapy with cisplatin and gemcitabine for the treatment of loco-regionally advanced cervical cancer
  Cihoric N., Tsikkinis A., Aebersold D., Lössl K. et al
  https://doi.org/10.1186/s13014-017-0938-1 (Radiation Oncology Journal)
• 12/2016: Current status and perspectives of interventional clinical trials for Glioblastoma – analysis of ClinicalTrials.gov Tsikkinis A., Cihoric N., Niyazi M. et al
  http://dx.doi.org/10.1186/s13014-016-0740-5 (Radiation Oncology Journal)
• 03/2016: Portfolio of prospective clinical trials including brachytherapy; An analysis of the ClinicalTrials.gov database.
  Tsikkinis A., Cihoric N., Aebersold D., Ghadjar P., Lössl K. et al
  http://dx.doi.org/10.1186/s13014-016-0624-8 (Radiation Oncology Journal)
• 11/2015: Dose escalated IMRT in the treatment of cervical cancer patients Cihoric N., Tsikkinis A., Tapia C., Aebersold D., Lössl K. et al
  http://dx.doi.org/10.1186/s13014-015-0551-0 (Radiation Oncology Journal)
• 06/2015: Clinical perspectives from Randomized Phase 3 trials on Prostate Cancer: An Analysis of the ClinicalTrials.gov Database
  Tsikkinis A., Cihoric N., Aebersold D., Ghadjar P. et al
  http://dx.doi.org/10.1016/j.euf.2015.05.003 (European Urology Focus)
• 05/2015: Hyperthermia-related clinical trials on cancer treatment within the ClinicalTrials.gov registry
  Cihoric N., Tsikkinis A., Aebersold D., Ghadjar P. et al
  http://dx.doi.org/10.3109/02656736.2015.1040471 (International Journal of Hyperthermia)

Submitted Publications (Under Review)

• Under Review: State of the art treatment options in the management of prostate cancer.
  Current trends and upcoming treatment options.
• Under Review: Clinical factors associated with the recurrence of operated nonfunctioning pituitary adenomas: a study on 203 patients.

Letters to the Editor

• 12/2018: A step forward in cancer informatics – it is mandatory to make guidelines machine readable
  Cihoric N., Igrutinovic I., Tsikkinis A.
  http://dx.doi.org/10.5166/jroi-9-1-1 (Journal of Radiation Oncology Informatics)
• 02/2016: Treatment options for isolated loco regional recurrences of NSCLC after surgery. Yes, Radiation Therapy, Too!
  Cihoric N., Tsikkinis A., Filipovic N., Jeremic B.
  http://dx.doi.org/10.1183/13993003.00388-2016 (European Respiratory Journal)

Invited Articles

• 12/2015: Analysis of clinical trials in Radiation Oncology: A characterization of the ClinicalTrials.gov Database
  Tsikkinis A., Cihoric N., Aebersold D., Zaugg K.
  (Schweizer Krebsbulletin; Issue 35, December 2015)
• 11/2018: A Gentle Introduction to Dictionaries, Terminologies, Classifications, Thesauruses, Ontologies and other Lexical Resources in Oncology Research – A mini review – Cihoric N., Vlaskou BE, Aebersold D., Tsikkinis A.

Abstracts

• SASRO 19: Benefits of an additional MRI for adaptive HDR-brachytherapy in gynaecological cancers
• ESTRO 19: Multi-institutional treatment and management of cervical cancer patients
• ESTRO 19: Observational study on partial breast irradiation conducted with interstitial multicatheter HDR brachytherapy for breast cancer after breast conserving surgery.
• ESTRO 19: The role of 18FDG -PET/CT in treatment response assessment and follow-up of cervical cancer after definitive radio/chemotherapy
• SASRO 18: Multi-institutional treatment of patients with cervical cancer in Switzerland
• SASRO 18: Value of 18F-FDG PET/CT in the follow up of cervical cancer patients
• UROK 18: Plan comparison of IRIS based and InCise 2 Multileaf Collimator based Radiosurgery for brain and liver Tumors
• ESTRO 18: Clinical trials in 15 malignancies with the highest mortality rate on a global scale.
• ASTRO 17: Cisplatin and gemcitabine combined with highly conformal external beam radiation therapy in the treatment of cervical cancer patients results in low toxicity and promising outcome
  http://dx.doi.org/10.1016/j.ijrobp.2017.06.1288 (Red Journal)
• ESMO 16: Abiraterone acetate followed by randomization to Dasatinib or Sunitinib malate in metastatic castrate resistant prostate cancer (mCRPC)
  http://dx.doi.org/10.1093/annonc/mdw372.11 (Annals of Oncology)
• ASTRO 16: Bladder-Preserving Combined-Modality Therapy: What is Coming Next? A Critical Analysis of Phase 2-3 Trials of the ClinicalTrials.gov Database
  http://dx.doi.org/10.1016/j.ijrobp.2016.06.1335 (Red Journal)
• ASCO 16: Neoadjuvant Enzalutamide and Abiraterone acetate plus leuprolide acetate (LHRHa) versus AA+ LHRHa in localized high-risk prostate cancer
• SGC 16: Contemporary surgical phase III clinical trials investigating colorectal carcinoma. An Analysis of the ClinicalTrials.gov database
• SASRO 15: Portfolio of prospective clinical trials including brachytherapy; An analysis of the ClinicalTrials.gov database
• ESHO 15: Inventory of hyperthermia related clinical trials as registered in ClinicalTrials.gov
• ASTRO 14: A comprehensive analysis of the ClinicalTrials.gov database; Focus on radiation oncology
  http://dx.doi.org/10.1016%2Fj.ijrobp.2014.05.1750 (Red Journal)
• SASRO 14: VMAT Radiotherapy with concomitant cisplatin and gemcitabine for the treatment of loco-regionally advanced cervical cancer
• SASRO 14: Landscape of radiation-oncology clinical trials in gynaecological malignancies: a comprehensive analysis of the ClinicalTrials.gov database

Unpublished Work

• Manuscript Abiraterone acetate and dasatinib or sunitinib in men with metastatic castration-Preparation resistant prostate cancer progressing on Abiraterone acetate alone (2010-0070): a randomised phase 2 trial. Tsikkinis A., Efstathiou E., Logothetis C. et al
• Manuscript Perspectives in the Treatment of Bladder Cancer: A Critical Analysis of the Next Preparation Phase II and III Trials of the ClinicalTrials.gov Database